Primary Site >> Pancreatic Cancer
Gene >> CEACAM6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Carcinofetal antigens. II. Carcinoembryonic antigen (CEA). (author's transl)]. PMID: 1080218 |
Ref: Pancreatic oncofetal antigen in pancreatic juices. Partial chemical characterization and diagnostic application of a pancreatic cancer-associated antigen. PMID: 7336130 |
Ref: Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias. PMID: 3004013 Ref: [Biliary carcinoembryonic antigen, non-specific cross-reacting antigen and biliary glycoprotein--their analysis and clinical aspects]. PMID: 3537682 |
Ref: [Boron neutron capture therapy using 10B entrapped anti-CEA immunoliposome]. PMID: 2519218 |
Ref: TDM35--a new monoclonal antibody to the XH1 cervical carcinoma cell line. Characterization and immunoperoxidase localization in benign and malignant tissues. PMID: 1403358 |
Ref: Cis-acting elements required for expression of the nonspecific cross-reacting antigen gene in colorectal carcinoma. PMID: 9041239 |
Ref: Differential display of expressed genes in pancreatic cancer cells. PMID: 12054612 |
Ref: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. PMID: 15208677 Ref: Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. PMID: 15383794 |
Ref: CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. PMID: 15729073 |
Ref: Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. PMID: 17201906 Ref: MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. PMID: 17406026 |
Ref: Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. PMID: 19055478 Ref: Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer. PMID: 19244123 Ref: CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. PMID: 19411761 |
Ref: Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. PMID: 20553613 |
Ref: Molecular targeting of CEACAM6 using antibody probes of different sizes. PMID: 22568933 |
Ref: CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. PMID: 23027178 Ref: Effective combination gene therapy using CEACAM6-shRNA and the fusion suicide gene yCDglyTK for pancreatic carcinoma in vitro. PMID: 23251258 Ref: CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. PMID: 23857344 Ref: Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers. PMID: 24186057 |
Ref: Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells. PMID: 22918079 Ref: Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. PMID: 25409014 |
Ref: [The effects of CEACAM6 and FOXP3 on tumor infiltrating lymphocytes and prognosis in patients with pancreatic cancer]. PMID: 26271985 |
Ref: Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma. PMID: 26497080 Ref: Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells. PMID: 27172290 |
Ref: Methylation of Tumor Suppressor Genes in Autoimmune Pancreatitis. PMID: 28196014 |